Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome

Published:2014-09-10 Issue:10 Volume:312 Page:1006
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

O’Donoghue Michelle L.¹,Braunwald Eugene¹,White Harvey D.²,Steen Dylan P.¹,Lukas Mary Ann³,Tarka Elizabeth⁴,Steg P. Gabriel⁵,Hochman Judith S.⁶,Bode Christoph⁷,Maggioni Aldo P.⁸,Im KyungAh¹,Shannon Jennifer B.⁹,Davies Richard Y.⁴,Murphy Sabina A.¹,Crugnale Sharon E.¹,Wiviott Stephen D.¹,Bonaca Marc P.¹,Watson David F.⁹,Weaver W. Douglas¹⁰,Serruys Patrick W.¹¹,Cannon Christopher P.¹

Affiliation:

1. TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts

2. Green Lane Cardiovascular Service, Auckland City Hospital, Auckland University, Auckland, New Zealand

3. Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, Philadelphia, Pennsylvania

4. Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, Pennsylvania

5. Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, and Université Paris-Diderot, Paris, France6NHLI Imperial College, ICMS Royal Brompton Hospital, United Kingdom

6. Department of Medicine, NYU Langone Medical Center, New York

7. Heart Center, Department for Cardiology and Angiology I, University of Freiburg, Freiburg, Germany

8. ANMCO Research Center, Florence, Italy

9. Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, Research Triangle Park, North Carolina

10. Henry Ford Heart and Vascular Institute, Detroit, Michigan

11. Erasmus University, Thoraxcentrum, Rotterdam, the Netherlands13International Center for Circulatory Health, Imperial College, London, United Kingdom

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 385 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipoprotein-associated phospholipase A2 activity levels is associated with artery to artery embolism in symptomatic intracranial atherosclerotic disease;Journal of Stroke and Cerebrovascular Diseases;2024-11

2. Agreement Between Mega-Trials and Smaller Trials;JAMA Network Open;2024-09-06

3. Anti‐inflammatory effects of natural products from vitamin C‐rich fruits;Food Frontiers;2024-09-04

4. La phospholipase A2 associée aux lipoprotéines (Lp-PLA2) : biomarqueur pertinent et cible thérapeutique ?;Annales Pharmaceutiques Françaises;2024-09

5. Colchicine, a Novel Treatment of Peripheral Artery Disease;Mayo Clinic Proceedings;2024-09